25Jan
Colorectal cancer – a new way to control the efficiency of chemotherapy
yezryy | Category: Healthcare news, Medical science | No Comments
German scientists came up with the discovery of a new biomarker which could be controlled to assess a response to chemotherapy of colorectal cancer. Indication of methylation of transcription factor AP-2 epsilon (TFAP2E) gens can be useful medical examination, helping to determine a chemotherapy resistance. (1,2) Read full text »
